More about

Schizophrenia

News
March 08, 2021
1 min read
Save

Novel glycine transporter inhibitor effective for improving cognition in schizophrenia

A novel glycine transporter inhibitor improved cognition after 12 weeks among individuals with schizophrenia, according to results of a double-blind, randomized, placebo-controlled phase 2 study published in The Lancet Psychiatry.

News
March 04, 2021
2 min read
Save

Researchers find link between metabolic disorders, cognitive deficits in schizophrenia

Researchers find link between metabolic disorders, cognitive deficits in schizophrenia

The presence of metabolic disorders appeared significantly linked to cognitive deficits among individuals with schizophrenia, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

News
February 26, 2021
2 min read
Save

LAI formulations of paliperidone, aripiprazole, olanzapine have highest effect sizes

LAI formulations of paliperidone, aripiprazole, olanzapine have highest effect sizes

Long-acting injectable formulations of paliperidone, aripiprazole and olanzapine had the highest effect sizes and certainty of evidence for relapse prevention and acceptability, researchers noted in American Journal of Psychiatry.

News
February 10, 2021
2 min read
Save

Study finds uncommonly assessed variables linked to schizophrenia functional outcomes

Baseline variables not routinely assessed and targeted by intervention programs in community mental health services were linked to functional outcomes at follow-up for schizophrenia, according to study results published in JAMA Psychiatry.

News
January 28, 2021
2 min read
Save

Schizophrenia diagnosis among top risk factors for mortality in COVID-19 patients

Schizophrenia diagnosis among top risk factors for mortality in COVID-19 patients

Schizophrenia spectrum disorder diagnosis appeared to be a significant risk factor for mortality among individuals with COVID-19, according to results of a retrospective cohort study published in JAMA Psychiatry.

News
January 27, 2021
2 min read
Save

Clozapine 'optimal treatment' for violent schizophrenia patients with conduct disorder

Clozapine appeared to be the optimal treatment for violent schizophrenia patients with conduct disorder, according to study results published in American Journal of Psychiatry.

News
January 26, 2021
1 min read
Save

Schizophrenia may increase risk for Parkinson’s disease

Schizophrenia spectrum disorder was linked to an increased risk for Parkinson’s disease later in life, according to study results published in Movement Disorders.

News
January 21, 2021
1 min read
Save

LAI paliperidone use during early schizophrenia phases linked to better outcomes

Long-acting injectable paliperidone use was associated with significant improvement in clinical and functional outcomes among individuals with schizophrenia, according to study results published in Journal of Clinical Psychiatry.

News
December 21, 2020
1 min read
Save

Physical activity may not mitigate schizophrenia risk

Physical activity may not mitigate schizophrenia risk

Physical activity did not appear to have preventive effects for schizophrenia, according to results of a two-sample mendelian randomization analysis published in JAMA Psychiatry.

News
December 17, 2020
1 min read
Save

Asenapine patch efficacious, safe for adults with schizophrenia

An asenapine transdermal system appeared effective for treating schizophrenia, according to results of a phase 3, randomized, placebo-controlled study published in Journal of Clinical Psychiatry.

View more